Getein Biotech, Inc

Short Term Long Term Short Term Comparison Long Term Comparison
  • 603387
  • 1d-2.25%
  • 1w-3.76%
  • 1m-3.87%
  • 1y-34.44%
ATH
  • ATH Price$21.49
  • ATH Date2020-07-10
  • % since ATH-59.52%
  • % to ATH147.06%
ATL
  • ATL Price$7.55
  • ATL Date2017-07-17
  • % from ATL15.25%
  • Last Low Price$7.73
  • Last Low Date2024-02-05
  • % From Last Low12.55%
IPO
  • IPO Price$32.04
  • % Current ROI USD-72.85%
  • ATH Price$21.49
  • % ROI ATH 28,473.31%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="603387"]

Key Data [addtoany]

Current price $8.7
Sector Healthcare
Industry Medical Devices
Today's High/Low $9/$8.6
Volume 1,760,132.00
Previous Close $8.9
52 Week High/Low $14.3359/$7.44
Market Cap 4,513,670,144.00
P/E Ratio 17.8
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0.0449
$8.7
[addtoany]

Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic products in China and internationally.
The company provides diagnostic reagents and analyzers; calibrators; reagent raw materials, such as monoclonal and polyclonal antibodies, antigen, antiserum, and microsphere; and cardiac marker, inflammation, renal function, coagulation, thyroid function, fertility, diabetes care, and thrombus products.
It also offers products in the area of cardiovascular, inflammatory, diabetes, fertility, renal, liver, and others.
The company was founded in 2002 and is headquartered in Nanjing, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity